Zubeda Khatoon
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Zubeda Khatoon has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Dilyana Branimirova Mangarova
Department of Radiology, Charité—Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Charitéplatz 1, 10117 Berlin, Germany
1 shared publication - Edwin Chang
Stanford University School of Medicine, Palo Alto, CA
1 shared publication - Giacomo Annio
Center for Research on Inflammation, INSERM UMR 1149 University Paris Cité Paris France
1 shared publication - Giovanni Marco Saladino
Department of Radiology, School of Medicine, Stanford University, Stanford, CA 94305, USA
1 shared publication - Goreti Ribeiro Morais
Institute of Cancer Therapeutics, Faculty of Life Sciences, University of Bradford, Bradford BD7 1DP, UK
1 shared publication - Grigory Tikhomirov
Department of Electrical Engineering and Computer Sciences, University of California Berkeley, Berkeley, CA, USA.
1 shared publication
Latest Publications
- Open Access
- 19 March 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (16) , 9986-9995
Multimodal imaging approach to track theranostic nanoparticle accumulation in glioblastoma with magnetic resonance imaging and intravital microscopy
Magnetic resonance imaging and two-photon intravital microscopy metrics were correlated to track Ferumoxytol-based theranostic nanoparticles targeting glioblastoma multiforme in vivo at both macroscopic and microscopic levels.
- 19 March 2025
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 17 (16) , 9986-9995
Open AccessMultimodal imaging approach to track theranostic nanoparticle accumulation in glioblastoma with magnetic resonance imaging and intravital microscopy
Magnetic resonance imaging and two-photon intravital microscopy metrics were correlated to track Ferumoxytol-based theranostic nanoparticles targeting glioblastoma multiforme in vivo at both macroscopic and microscopic levels.